OpenResearchAlpha

Nature Communications · 11 Nov 2026

Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial

Minna Laineh-index 2, Antje Banning, Viljami Sairanen, Günter Lochnit, Timo Roine, Elina L. Harjunen, Ulrika Roine, Anna M. Tokola, Hanna Terinkoski, Daniel Leufkens, Päivi Helenius, Taina H. Autti, Ritva Tikkanenh-index 34

0
Citations
no database records one yet
0
Citations in 2026
so far
34
Leading author's h-index
Ritva Tikkanen, in QAI's scholar index
71
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract This phase Ib/II investigator-initiated, open label trial aims to show the safety and efficacy of Cystadane (betaine) in aspartylglucosaminuria, a lysosomal storage disorder characterized by progressive cognitive decline, in Finnish patients homozygous for the Finnish major mutation, aged between 3 and 17 years at study begin (recruited: 25, analyzed: 21). Oral Cystadane efficacy and safety were studied over 48 months. The primary endpoint of the study, reduction of glycoasparagines in the urine, was quantitatively determined using liquid chromatography/mass spectrometry and normalized to urine creatinine. Urine glycoasparagines are significantly reduced upon Cystadane treatment (by 68.6% ±10.8%; p = 0.000), and the study thus meets its primary endpoint. Our data show that Cystadane/betaine efficiently improves the main disease biomarker, and it is safe to use in aspartylglucosaminuria. Further studies should be carried out in a larger patient population over a longer time to demonstrate the effects on disease progression. EudraCT registration number 2017-000645-48.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Ritva Tikkanen has the highest h-index among the authors (34).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (13)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (71)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 51 more references

A free account opens the rest of the citing papers and references on every paper’s page.